Skip to main content

Crohn’s Disease

Hightower’s previous studies focused on advancing therapies for Crohn’s disease, addressing the complexities of this chronic condition.


About Crohn’s Disease Clinical Trials

Crohn’s Disease is a form of Inflammatory Bowel Disease (IBD) impacting over 500,000 Americans. It causes inflammation in the digestive tract and symptoms such as abdominal pain, malnutrition, diarrhea, fatigue, and weight loss. Although it primarily affects intestinal walls, it can involve any part of the digestive system.

Hightower Clinical conducted multiple clinical trials on Crohn’s Disease, evaluating the safety and efficacy of investigational drugs across patients with varying severity levels. Additionally, compared study drugs with those already available in the market. This groundbreaking research aimed to improve treatment outcomes and enhance the quality of life.

Current Status

Not Recruiting

Study Count


Study Information

Crohn’s Disease

Study NameProtocol NumberSponsor
Crohn’s DiseaseM20-371Abbvie

Frequently Asked Questions

Is Crohn’s Disease caused by an unhealthy lifestyle?

No, Crohn’s disease is not linked to infections or dietary factors. Rather, it stems from gut inflammation triggered by an overactive immune response. Its exact cause remains unknown

Can Crohn’s Disease lead to Cancer?

No, Crohn’s disease typically does not increase the risk of cancer, except in cases where it affects the ileum (the final part of the small intestine). However, regular follow-ups are advisable after 8-10 years post-diagnosis to monitor for any potential complications.

What are the potential risks participating in a clinical trial?

Potential risks include side effects and uncertainties about treatment effectiveness. It’s important to weigh the potential benefits against the risks and discuss any concerns with the trial team.

How can I find out if I am eligible for the clinical trial?

Each clinical trial has specific criteria for participant inclusion and exclusion. If you’re interested in joining Crohn’s Disease Clinical Trials, review the eligibility criteria or contact us for further information.